
TRACON Pharmaceuticals TCON
TRACON Pharmaceuticals Current Ratio | TCON
Current Ratio Jährlich TRACON Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.17 | 2.12 | 1.89 | 2.63 | 2.37 | 0.543 | 0.0871 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.63 | 0.0871 | 1.54 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AVEO Pharmaceuticals
AVEO
|
1.77 | - | - | $ 521 M | ||
|
Cyclerion Therapeutics
CYCN
|
2.06 | $ 34.99 | 3.77 % | $ 147 M | ||
|
Seelos Therapeutics
SEEL
|
0.139 | - | -47.76 % | $ 6.27 M | ||
|
Завод ДИОД
DIOD
|
8.75 | - | - | - | ||
|
Kiromic BioPharma
KRBP
|
0.404 | - | 6.61 % | $ 3.08 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.86 | - | - | $ 2.18 B | ||
|
Fusion Pharmaceuticals
FUSN
|
4.51 | - | - | $ 1.41 B | ||
|
Gritstone Oncology
GRTS
|
1.41 | - | 0.42 % | $ 213 M | ||
|
Aridis Pharmaceuticals
ARDS
|
0.378 | - | 17.91 % | $ 11.1 M | ||
|
Titan Pharmaceuticals
TTNP
|
6.05 | - | -3.76 % | $ 3.47 M | ||
|
HOOKIPA Pharma
HOOK
|
2.63 | - | -6.92 % | $ 79.4 M | ||
|
Otonomy
OTIC
|
2.35 | - | -1.96 % | $ 4.68 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
2.87 | $ 286.96 | 0.01 % | $ 5.55 B | ||
|
Фармсинтез
LIFE
|
0.454 | - | - | - | ||
|
Actinium Pharmaceuticals
ATNM
|
1.18 | $ 1.04 | -4.59 % | $ 32.4 M | ||
|
Oncternal Therapeutics
ONCT
|
5.5 | - | -24.12 % | $ 1.56 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
Concert Pharmaceuticals
CNCE
|
3.11 | - | - | $ 401 M | ||
|
Histogen
HSTO
|
3.35 | - | 31.6 % | $ 2.12 M | ||
|
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
0.629 | - | -7.23 % | $ 13 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
5.28 | - | - | $ 1.62 B | ||
|
Omeros Corporation
OMER
|
1.87 | $ 13.23 | -5.71 % | $ 840 M | ||
|
BioLineRx Ltd.
BLRX
|
2.33 | $ 0.94 | -10.44 % | $ 2.32 B | ||
|
PhaseBio Pharmaceuticals
PHAS
|
0.394 | - | 7.4 % | $ 6.29 M | ||
|
Forma Therapeutics Holdings
FMTX
|
8.95 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
1.34 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
1.97 | - | - | $ 26.6 B | ||
|
Provention Bio
PRVB
|
2.06 | - | - | $ 2.37 B | ||
|
Reata Pharmaceuticals
RETA
|
1.6 | - | - | $ 6.29 B | ||
|
PainReform Ltd.
PRFX
|
4.43 | $ 0.47 | -24.53 % | $ 305 K | ||
|
iTeos Therapeutics
ITOS
|
7.11 | - | - | $ 411 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 1.44 | -2.03 % | $ 2.37 M | ||
|
PolarityTE
PTE
|
3.67 | - | -0.82 % | $ 1.78 M | ||
|
Kronos Bio
KRON
|
3.38 | - | 1.49 % | $ 50.8 M | ||
|
Cullinan Management
CGEM
|
11.3 | $ 8.9 | -1.93 % | $ 536 M | ||
|
CRISPR Therapeutics AG
CRSP
|
6.6 | $ 39.15 | 0.57 % | $ 3.52 B | ||
|
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M | ||
|
Stoke Therapeutics
STOK
|
6.34 | $ 26.77 | -0.59 % | $ 1.59 B | ||
|
Trevena
TRVN
|
0.841 | - | -46.58 % | $ 31.8 M | ||
|
Calithera Biosciences
CALA
|
3.46 | - | -10.95 % | $ 876 K | ||
|
Molecular Templates
MTEM
|
1.14 | - | -23.43 % | $ 495 K | ||
|
Oncorus
ONCR
|
1.71 | - | -8.54 % | $ 3.19 M | ||
|
BioXcel Therapeutics
BTAI
|
0.32 | $ 0.07 | 9.81 % | $ 855 K | ||
|
Novan
NOVN
|
1.05 | - | -24.84 % | $ 2.64 M | ||
|
CohBar
CWBR
|
15.8 | - | -15.44 % | $ 2.2 M | ||
|
NeuBase Therapeutics
NBSE
|
3.48 | - | -1.56 % | $ 12.3 M | ||
|
Epizyme
EPZM
|
1.64 | - | - | $ 249 M | ||
|
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | ||
|
Scopus BioPharma
SCPS
|
0.519 | - | -48.37 % | $ 3.71 M |